Home Cart Sign in  
Chemical Structure| 1119-34-2 Chemical Structure| 1119-34-2

Structure of H-Arg-OH·HCl
CAS No.: 1119-34-2

Chemical Structure| 1119-34-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

L-Arginine HCl is a substrate of NOS and a nonessential amino acid in human.

Synonyms: (S)-(+)-Arginine hydrochloride; L-Arginine hydrochloride; Levargin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of H-Arg-OH·HCl

CAS No. :1119-34-2
Formula : C6H15ClN4O2
M.W : 210.66
SMILES Code : O=C(O)[C@@H](N)CCCNC(N)=N.[H]Cl
Synonyms :
(S)-(+)-Arginine hydrochloride; L-Arginine hydrochloride; Levargin
MDL No. :MFCD00064550
InChI Key :KWTQSFXGGICVPE-WCCKRBBISA-N
Pubchem ID :66250

Safety of H-Arg-OH·HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
AR42J cells 1 mM and 2.5 mM 3 to 12 hours To investigate the effect of L-arginine on NCX1 protein expression. Results showed that 1 mM and 2.5 mM L-arginine treatment for 3 to 12 hours gradually increased NCX1 protein expression, with a more distinct trend in the 1 mM treatment group. PMC6946105
Porcine alveolar macrophages (PAM) 2, 5, 10, 20, 40 mM 24 hours pretreatment, 72 hours post-infection To study the effect of L-Arginine on ASFV replication, it was found that L-Arginine concentrations above 20 mM significantly promoted ASFV replication PMC8310191

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats L-arginine-induced acute pancreatitis model Intraperitoneal injection 2.5 g/kg Twice, 1 hour apart To investigate the expression changes of NCX1 and NF-κB in the L-arginine-induced acute pancreatitis model. Results showed that between 3 and 12 hours after L-arginine treatment, pancreatic tissue exhibited early to middle phases of acute inflammation, with gradual increases in NCX1 and NF-κB expression. PMC6946105
C57BL/6 mice L-Arginine-induced acute pancreatitis model Intraperitoneal injection 4 g/kg body weight Hourly injection, a total of two times Induced acute pancreatitis, leading to pancreatic tissue necrosis and inflammatory cell infiltration PMC10609823
Mice UT-A1/3−/− mice Intravenous injection 1 μg/g BW Single injection To evaluate the effect of L-NAME on renal blood flow in UT-A1/3?/? mice. Results showed that L-NAME caused a significant decrease in renal blood flow, with a greater percentage decrease in UT-A1/3?/? mice compared to wild-type mice. PMC1435686

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05855330 COVID-19 PHASE2 RECRUITING 2025-06-25 Children's Healthcare of Atlan... More >>ta (CHOA), Egleston, Atlanta, Georgia, 30322, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.75mL

0.95mL

0.47mL

23.73mL

4.75mL

2.37mL

47.47mL

9.49mL

4.75mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories